Far-UVC light is a specialized form of ultraviolet (UV) light that has demonstrated remarkable efficacy in neutralizing microbes and viruses while maintaining safety for humans. Dr. David Brenner, a leading radiation scientist, has been at the forefront of research into this technology. His work explores how far-UVC light could transform public health by reducing the spread of viruses like SARS-CoV-2, the pathogen responsible for COVID-19.
The Promise of Far-UVC Light
Over the past eight years, Dr. Brenner and his research team have focused on developing far-UVC light to combat viruses and bacteria, including those resistant to conventional treatments. Far-UVC light operates at a wavelength of approximately 222 nanometers (nm), which is effective at killing pathogens without causing harm to human skin or eyes.
Dr. Brenner leads the Center for Radiological Research at Columbia University Irving Medical Center, a pioneer in radiation science established by a student of Marie Curie. The Center’s mission is to leverage radiation technology to enhance human health and medical care.
Advantages of Far-UVC Light
Safe for Human Exposure: Far-UVC light is absorbed by the outer layer of dead skin cells and the cornea of the eyes, preventing it from penetrating deeper into living tissue. This characteristic allows it to be used continuously in occupied spaces without the risks associated with traditional UV light, such as sunburn or skin cancer.
Effective Pathogen Neutralization: Far-UVC light is highly effective in deactivating viruses and bacteria by disrupting their DNA and RNA structures. This makes it a powerful tool for reducing the presence of airborne pathogens, including SARS-CoV-2 and drug-resistant bacteria.
Potential Applications: Dr. Brenner suggests that far-UVC light could be used in a variety of settings, including hospitals, nursing homes, trains, and other public indoor spaces. This technology has the potential to significantly curb the spread of infectious diseases in high-traffic areas.
Care222 Technology by Ushio
Ushio, a leader in UV technology, holds exclusive rights to the far-UVC technology patented by Columbia University in 2012. Ushio’s Care222 technology utilizes this breakthrough to offer safe and effective disinfection solutions.
Care222 Features:
- Customized Solutions: Ushio develops products that can be tailored to various market needs, providing flexible disinfection solutions.
- Ceiling Installation: Designed for installation on ceilings, Care222 devices integrate seamlessly into existing environments without affecting the room’s aesthetics.
- Cost-Effective: The design of Care222 devices ensures easy installation and maintenance, contributing to overall cost savings.
- Eye Protection: The technology uses MCPET developed by Furukawa for indirect lighting, which helps reduce eye fatigue and offers additional protection.
Lumens Artemis Far-UVC Devices
Lumens has partnered with Ushio to incorporate Care222 technology into its Artemis Far-UVC Disinfection Devices. These devices are engineered to provide continuous disinfection in occupied spaces, ensuring a clean and safe environment without harming users.
Key Benefits of Lumens Artemis Devices
- Durability: Care222 modules maintain high performance over their lifespan, with minimal degradation, ensuring long-term reliability.
- Safety and Efficiency: The Artemis devices offer effective disinfection with no adverse effects on human health, making them suitable for use in various settings.
Conclusion
Far-UVC light represents a promising advancement in disinfection technology, offering a safe and efficient method for controlling airborne pathogens. With applications ranging from healthcare facilities to public transportation, this technology has the potential to play a crucial role in safeguarding public health. For more information on Care222 technology and its applications, visit www.care222.com.